It takes the average reader 5 hours and 59 minutes to read Quantitative Decisions in Drug Development by Christy Chuang-Stein
Assuming a reading speed of 250 words per minute. Learn more
This book focuses on important decision points and evidence needed for making decisions at these points during the development of a new drug. It takes a holistic approach towards drug development by incorporating explicitly knowledge learned from the earlier part of the development and available historical information into decisions at later stages. In addition, the book shares lessons learned from several select examples published in the literature since the publication of the first edition. The second edition reiterates the need for making evidence-based Go/No Go decisions in drug development discussed in the first edition. It substantially expands several topics that have seen great advances since the publication of the first edition. The most noticeable additions include three adaptive trials conducted in recent years that offer excellent learning opportunities, the use of historical data in the design and analysis of clinical trials, and extending decision criteria to the cases when the primary endpoint is binary. The examples used to illustrate the additional materials all come from real trials with some post-trial reflections offered by the authors. The book begins with an overview of product development and regulatory approval pathways. It then discusses how to incorporate prior knowledge into study design and decision making at different stages of drug development. Prior knowledge includes information pertaining to historical controls. To assist decision making, the book discusses appropriate metrics and the formulation of go/no-go decisions for progressing a drug candidate to the next development stage. Using the concept of the positive predictive value in the field of diagnostics, the book leads readers to the assessment of the probability that an investigational product is effective given positive study outcomes. Lastly, the book points out common mistakes made by drug developers under the current drug-development paradigm. The book offers useful insights to statisticians, clinicians, regulatory affairs managers and decision-makers in the pharmaceutical industry who have a basic understanding of the drug-development process and the clinical trials conducted to support drug-marketing authorization. The authors provide software codes for select analytical approaches discussed in the book. The book includes enough technical details to allow statisticians to replicate the quantitative illustrations so that they can generate information to facilitate decision-making themselves.
Quantitative Decisions in Drug Development by Christy Chuang-Stein is 354 pages long, and a total of 89,916 words.
This makes it 119% the length of the average book. It also has 110% more words than the average book.
The average oral reading speed is 183 words per minute. This means it takes 8 hours and 11 minutes to read Quantitative Decisions in Drug Development aloud.
Quantitative Decisions in Drug Development is suitable for students ages 12 and up.
Note that there may be other factors that effect this rating besides length that are not factored in on this page. This may include things like complex language or sensitive topics not suitable for students of certain ages.
When deciding what to show young students always use your best judgement and consult a professional.
Quantitative Decisions in Drug Development by Christy Chuang-Stein is sold by several retailers and bookshops. However, Read Time works with Amazon to provide an easier way to purchase books.
To buy Quantitative Decisions in Drug Development by Christy Chuang-Stein on Amazon click the button below.
Buy Quantitative Decisions in Drug Development on Amazon